Position in TGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,651,615
+$9,598,657 QoQ
Shares Held
375,894
+13.0% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 426 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$35,990
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. TGTX ranks #12 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in TGTX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,651,615 | 375,894 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,052,958 | 332,720 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $11,795,220 | 395,680 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $9,850,094 | 272,667 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,394,037 | 316,589 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $35,990 | 1,000 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $11,574,280 | 293,540 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,975,229 | 331,403 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,180,283 | 178,721 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,769,439 | 155,674 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,214,106 | 79,823 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,100,771 | 64,448 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,760,722 | 210,613 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,601,202 | 144,976 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,999,973 | 132,977 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $341,271 | 28,848 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $210,709 | 35,593 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $197,394 | 46,446 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $103,659 | 10,900 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $103,659 | 10,900 | Call | Defined | 2022-05-16 | |
| 2022-03-31 | $871,693 | 91,661 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,694,409 | 141,811 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,135,039 | 94,202 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,634,149 | 67,908 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,836,151 | 121,082 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,396,651 | 161,412 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,558,622 | 132,983 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,508,281 | 128,762 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $602,352 | 61,215 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||